Chlamydia are Gram-negative, intracellular pathogens colonizing epithelial mucosa. They cause primarily atypical pneumonia and have recently been associated with chronic diseases. Diagnostics relies almost exclusively on serological methods; PCR tests are used rarely because in patients with positive ELISA, it is nearly impossible to identify chlamydial DNA. This paradox is associated with DNA degradation in sputum samples, low abundance, and low sensitivity of PCR systems. In a newly designed and validated “nested” PCR (NPCR) assay, it was possible to amplify DNA of Chlamydia known to infect humans in 31% samples. The reliability of the assay was confirmed by DNA sequencing, and all PCR products belonged exclusively to the Chlamydiales, mainly recognized as Chlamydia pneumoniae. Three samples were related to Ca. Rhabdochlamydia porcellionis and Ca. Renichlamydia lutjani, which infect arthropods. In one case, samples were taken from sick individual, indicating the potential as a human pathogen.
Chlamydia are Gram-negative, intracellular pathogens colonizing the epithelial mucosa. They cause primarily atypical pneumonia and have recently been associated with chronic diseases. Diagnostics rely almost exclusively on serological methods; PCR tests are used rarely because in patients with positive ELISA, it is nearly impossible to identify chlamydial DNA. To understand this issue, we elaborated a reliable and sensitive nested PCR method (panNPCR) for identifying all Chlamydiales species, not only in sputa, but also in clotted blood. Sequencing of the PCR product revealed that 41% of positive sputa samples and 66% of positive blood samples were not infected by Chlamydia but with “Chlamydia-related bacteria” such as Rhabdochlamydia sp., Parachlamydia sp., Protochlamydia sp., Neochlamydia sp., Mesochlamydia elodeae and lacustris, Piscichlamydia salmonis, and Estrella lausannensis. Consequently, we propose that there might be more than four human pathogenic Chlamydia species. We did not find any clear correlation between increased levels of antibodies and the presence of their DNA. Chlamydialles DNA was found in sputa samples from individuals positive for IgG or IgA but not in blood samples. Thus, elevated IgG and IgA levels are not reliable markers of chronic infection, and the presence of persistent forms should be proved by panNPCR. Apparently, the differences between ELISA and DNA amplification results have three main methodological reasons. The first one is the threshold occurrence of chlamydial genetic material in sputum and blood. The second one is the fact that a significant part of the samples can have DNA with sequences different from those of other species of the order Chlamydiales. The third one is the high background characteristic for ELISA, the absence of paired sera, and the vague interpretation of the gray zone.
Background/objectives: The study aims to investigate potential differences in vertical jump performance between elite basketball and volleyball players before and after a standard training session, in comparison to a control group from the general population. The analysis focuses on the influence of selected gene polymorphisms that may contribute to variations in the assessed performance parameters. Aims: The aim was to investigate the influence of ACE (rs4646994), ACTN3 (rs1815739), PPARA rs4253778, HIF1A (rs11549465), and AMPD1 (rs17602729) genes polymorphisms on the combined effects of post-activation potentiation (PAP), post-activation performance enhancement (PAPE), and general adaptation syndrome (GAS), as reflected in vertical jump performance, in elite basketball and volleyball players compared to a control group from the general population. Methods: The effects of PAP at the beginning of the training load (acute exercise), and the combined influences of PAPE and GAS following the training load were evaluated using parameters measured by the OptoJump Next® system (Microgate, Bolzano, Italy). Results: A statistically significant (h, p < 0.05) negative effect of the CT genotype of the AMPD1 gene on jump height was observed in the group of athletes. The CT genotype of the AMPD1 gene negatively impacted on PAPE and GAS adaptive responses (ΔP, Δh, p < 0.001) also in the control group. A positive effect on the power during the active phase of the vertical jump was identified for the II genotype of the ACE gene and the Pro/Ser genotype of the HIF1A gene, both exclusively in the control group (ΔP, p < 0.05). Conclusion: Our findings demonstrate that different gene polymorphisms exert variable influences on the combined effects of PAPE and GAS, as reflected in vertical jump parameters, depending on the participants’ level of training adaptation.
H. pylori detection via the stool antigen test (SAT) requires 100 times more cells than nested PCR (NPCR) for a 454 bp amplicon, but is significantly more sensitive in identifying positive stool samples. To understand this contradiction, we developed an NPCR assay to amplify a shorter 148 bp segment of the 16S rRNA gene. The assay was extremely sensitive and reliable when adhering to particular rules commonly used in forensic laboratories. The SAT and NPCR for long and short amplicons were compared using stool samples from 208 gastroenterological patients, of which 27.9% were identified as positive according to the SAT and only 6.25% according to the 454 bp NPCR amplicon, but 51.0% in the short 148 bp NPCR. Among 100 asymptomatic volunteers, the prevalence was 35% in the SAT assay and 22% in the long NPCR, but as much as 66.6% of positives were determined in the short 148 bp NPCR. The specificity of the PCR product was determined via DNA sequencing, which confirmed H. pylori’s origin in all NPCR-positive samples. Apparently, the stool contains mostly short fragments of H. pylori DNA, and the most plausible explanation for the SAT/NPCR paradox is the degradation of H. pylori DNA in the digestive system.
Background: Biological maturity assessment is increasingly discussed in youth sport because chronological age alone does not reflect inter-individual variation in growth and pubertal timing. Ultrasound-based systems such as BAUSport™ provide a radiation-free alternative to radiographic skeletal age assessment. This exploratory cross-sectional study examined skeletal age (SA) in Slovak female volleyball players, track-and-field athletes, and non-athletes using BAUSport™, while acknowledging substantial age differences between groups. Methods: Eighty girls (55 non-athletes, 13 volleyball players, 12 track-and-field athletes; aged 6.85–14.41 years) underwent anthropometric measurement and skeletal age (SA) assessment with BAUSport™. Chronological age (CA) was calculated as decimal age from birth date to measurement date. Groups were not age-matched; volleyball players were on average markedly older than the other groups. Skeletal maturity was categorized as early, on-time, or late using a ±1.0-year SA–CA threshold. Menarche status was recorded as an indicator of pubertal development. Group differences were evaluated using chi-square or Fisher’s exact tests as appropriate, while differences in SA and SA–CA according to menarche status were assessed using Welch’s t-test. Results: Volleyball players were older (12.90 ± 0.95 years) than non-athletes (10.22 ± 2.40 years) and track-and-field athletes (8.47 ± 1.51 years). They also demonstrated the largest mean SA–CA difference (+1.98 ± 0.73 years). The distribution of maturity categories differed across groups (χ2(4) = 14.32, p = 0.006, Cramer’s V = 0.30). Post-menarcheal girls exhibited significantly higher skeletal age and SA–CA values compared to pre-menarcheal girls. However, the substantial age disparity between groups represents a primary confounding factor and limits interpretation of sport-specific effects. Conclusions: This study demonstrates the practical application of BAUSport™ for rapid, radiation-free skeletal age assessment in youth. Differences according to menarche status support the biological relevance of skeletal maturity assessment. However, no valid between-group sport-specific inferences can be made because the groups were not age-matched and puberty is the dominant driver of skeletal maturation. Larger, age-matched studies are required before drawing conclusions regarding sport-specific selection patterns.
The aim of our study is to substantiate and confirm the importance of the level of running stride parameters and explosive power of the lower limbs of young basketball players in achieving acceleration speed. The research population consisted of U13 (n = 11) and U15 (n = 16) players who have been participating in a regular specialized training program for at least 2 years. Testing was conducted using the Optojump next device in the 15 m acceleration race. The literature refers to the 1st and 2nd running steps as key. In our study, we focused on the evaluation of the first 6 running steps. We performed 3 vertical jump protocols (CMJ (counter movement jump), CMJ- free arms and SQ (squat jump)) to determine the level of explosive power of the lower limbs. We observed a significant relationship between the level of acceleration velocity and CMJ (p < 0.05, r = -0.610), CMJ-free arms (p < 0.05, r = -0.728) in the U13 category. In the U15 category, a significant relationship was found in CMJ (p < 0.01, r = - 0.720), CMJ-free arms (p < 0.01, r = - 0.688) and SQ (p < 0.01, r = - 0.872). In the U13 category, we observed a significant relationship between the level of acceleration speed at 15 m and pad contact time in the 4th (p < 0.01, r = 0.740) running stride. Running stride length was not significant with acceleration speed level in the U13 category. In the U15 category, we observed a significant relationship between the level of acceleration speed at 15 m and the contact time with the mat in the 1st (p < 0.05, r = 0.619), 3rd (p < 0.01, r = 0.709), 5th (p < 0.01, r = 0.783) and 6th (p < 0.05, r = 0.593) running stride. Running stride length in relation to acceleration velocity was not significant in either running stride in the U15 category.